US Stock MarketDetailed Quotes

OBLN Obalon Therapeutics

Watchlist
  • 0.000
  • 0.0000.00%
Close May 17 09:30 ET
0Market Cap0.00P/E (TTM)

Obalon Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
(Q2)Jun 30, 2020
(Q1)Mar 31, 2020
(FY)Dec 31, 2019
(Q4)Dec 31, 2019
(Q3)Sep 30, 2019
(Q2)Jun 30, 2019
Total revenue
0
-51.60%1.59M
-92.25%61K
-86.79%44K
82.12%703K
-56.06%780K
-63.95%3.28M
-61.35%787K
-88.85%333K
-85.87%386K
Operating revenue
--0
-51.60%1.59M
-92.25%61K
-86.79%44K
82.12%703K
-56.06%780K
-63.95%3.28M
-61.35%787K
-88.85%333K
-85.87%386K
Cost of revenue
0
-65.97%1M
-100.16%-1K
-90.05%41K
-37.70%423K
-56.09%541K
-45.60%2.95M
-58.31%627K
-70.94%412K
-60.80%679K
Gross profit
0
76.44%584K
-61.25%62K
103.80%3K
195.56%280K
-55.99%239K
-91.00%331K
-69.92%160K
-105.04%-79K
-129.30%-293K
Operating expense
-19.07%4.17M
-52.35%11.23M
-72.99%1.39M
-57.36%1.56M
-48.91%3.13M
-40.41%5.15M
-42.03%23.56M
-44.14%5.14M
-55.35%3.66M
-42.28%6.12M
Selling and administrative expenses
4.19%4.06M
-47.35%8.78M
-66.24%1.23M
-48.13%1.29M
-45.48%2.36M
-37.25%3.89M
-44.34%16.67M
-46.85%3.64M
-57.35%2.49M
-40.25%4.33M
Research and development costs
-91.09%112K
-64.46%2.45M
-89.48%157K
-76.92%271K
-57.21%765K
-48.46%1.26M
-35.56%6.89M
-36.18%1.49M
-50.42%1.17M
-46.66%1.79M
Operating profit
15.13%-4.17M
54.19%-10.64M
73.37%-1.33M
58.34%-1.56M
55.61%-2.85M
39.37%-4.91M
37.16%-23.23M
42.55%-4.98M
43.60%-3.74M
33.21%-6.41M
Net non-operating interest income expense
-97.14%1K
107.53%29K
0
-102.70%-1K
98.31%-5K
118.42%35K
-70.35%-385K
201.61%63K
152.86%37K
-417.54%-295K
Total other finance cost
97.14%-1K
-107.53%-29K
--0
102.70%1K
-98.31%5K
-118.42%-35K
70.35%385K
-201.61%-63K
-152.86%-37K
417.54%295K
Other net income (expense)
-2,721.31%-1.72M
0
-2,164.41%-1.34M
-385K
67.72%-61K
97.06%-1K
97.50%-1K
37.23%-59K
Special income (charges)
----
---1.31M
--0
--0
---1.31M
----
--0
--0
--0
--0
-Less:Impairment of capital assets
----
--1.31M
--0
--0
--1.31M
----
--0
--0
--0
--0
Other non- operating income (expenses)
----
-573.77%-411K
--0
----
55.93%-26K
---385K
67.72%-61K
97.06%-1K
97.50%-1K
37.23%-59K
Income before tax
20.79%-4.17M
47.91%-12.33M
73.03%-1.33M
57.91%-1.56M
38.11%-4.19M
36.54%-5.26M
36.66%-23.68M
43.89%-4.91M
45.06%-3.71M
30.62%-6.77M
Income tax
Net income
20.79%-4.17M
47.91%-12.33M
73.03%-1.33M
57.91%-1.56M
38.11%-4.19M
36.54%-5.26M
36.66%-23.68M
43.89%-4.91M
45.06%-3.71M
30.62%-6.77M
Net income continuous Operations
20.79%-4.17M
47.91%-12.33M
73.03%-1.33M
57.91%-1.56M
38.11%-4.19M
36.54%-5.26M
36.66%-23.68M
43.89%-4.91M
45.06%-3.71M
30.62%-6.77M
Minority interest income
Net income attributable to the parent company
20.79%-4.17M
47.91%-12.33M
73.03%-1.33M
57.91%-1.56M
38.11%-4.19M
36.54%-5.26M
36.66%-23.68M
43.89%-4.91M
45.06%-3.71M
30.62%-6.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
20.79%-4.17M
47.91%-12.33M
73.03%-1.33M
57.91%-1.56M
38.11%-4.19M
36.54%-5.26M
36.66%-23.68M
43.89%-4.91M
45.06%-3.71M
30.62%-6.77M
Basic earnings per share
35.29%-1.32
68.39%-4.77
73.44%-0.51
67.21%-0.6
78.57%-1.62
81.06%-2.04
74.39%-15.09
83.59%-1.92
82.42%-1.83
55.79%-7.56
Diluted earnings per share
35.29%-1.32
68.39%-4.77
73.44%-0.51
67.21%-0.6
78.57%-1.62
81.06%-2.04
74.39%-15.09
83.59%-1.92
82.42%-1.83
55.79%-7.56
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020(Q2)Jun 30, 2020(Q1)Mar 31, 2020(FY)Dec 31, 2019(Q4)Dec 31, 2019(Q3)Sep 30, 2019(Q2)Jun 30, 2019
Total revenue 0-51.60%1.59M-92.25%61K-86.79%44K82.12%703K-56.06%780K-63.95%3.28M-61.35%787K-88.85%333K-85.87%386K
Operating revenue --0-51.60%1.59M-92.25%61K-86.79%44K82.12%703K-56.06%780K-63.95%3.28M-61.35%787K-88.85%333K-85.87%386K
Cost of revenue 0-65.97%1M-100.16%-1K-90.05%41K-37.70%423K-56.09%541K-45.60%2.95M-58.31%627K-70.94%412K-60.80%679K
Gross profit 076.44%584K-61.25%62K103.80%3K195.56%280K-55.99%239K-91.00%331K-69.92%160K-105.04%-79K-129.30%-293K
Operating expense -19.07%4.17M-52.35%11.23M-72.99%1.39M-57.36%1.56M-48.91%3.13M-40.41%5.15M-42.03%23.56M-44.14%5.14M-55.35%3.66M-42.28%6.12M
Selling and administrative expenses 4.19%4.06M-47.35%8.78M-66.24%1.23M-48.13%1.29M-45.48%2.36M-37.25%3.89M-44.34%16.67M-46.85%3.64M-57.35%2.49M-40.25%4.33M
Research and development costs -91.09%112K-64.46%2.45M-89.48%157K-76.92%271K-57.21%765K-48.46%1.26M-35.56%6.89M-36.18%1.49M-50.42%1.17M-46.66%1.79M
Operating profit 15.13%-4.17M54.19%-10.64M73.37%-1.33M58.34%-1.56M55.61%-2.85M39.37%-4.91M37.16%-23.23M42.55%-4.98M43.60%-3.74M33.21%-6.41M
Net non-operating interest income expense -97.14%1K107.53%29K0-102.70%-1K98.31%-5K118.42%35K-70.35%-385K201.61%63K152.86%37K-417.54%-295K
Total other finance cost 97.14%-1K-107.53%-29K--0102.70%1K-98.31%5K-118.42%-35K70.35%385K-201.61%-63K-152.86%-37K417.54%295K
Other net income (expense) -2,721.31%-1.72M0-2,164.41%-1.34M-385K67.72%-61K97.06%-1K97.50%-1K37.23%-59K
Special income (charges) -------1.31M--0--0---1.31M------0--0--0--0
-Less:Impairment of capital assets ------1.31M--0--0--1.31M------0--0--0--0
Other non- operating income (expenses) -----573.77%-411K--0----55.93%-26K---385K67.72%-61K97.06%-1K97.50%-1K37.23%-59K
Income before tax 20.79%-4.17M47.91%-12.33M73.03%-1.33M57.91%-1.56M38.11%-4.19M36.54%-5.26M36.66%-23.68M43.89%-4.91M45.06%-3.71M30.62%-6.77M
Income tax
Net income 20.79%-4.17M47.91%-12.33M73.03%-1.33M57.91%-1.56M38.11%-4.19M36.54%-5.26M36.66%-23.68M43.89%-4.91M45.06%-3.71M30.62%-6.77M
Net income continuous Operations 20.79%-4.17M47.91%-12.33M73.03%-1.33M57.91%-1.56M38.11%-4.19M36.54%-5.26M36.66%-23.68M43.89%-4.91M45.06%-3.71M30.62%-6.77M
Minority interest income
Net income attributable to the parent company 20.79%-4.17M47.91%-12.33M73.03%-1.33M57.91%-1.56M38.11%-4.19M36.54%-5.26M36.66%-23.68M43.89%-4.91M45.06%-3.71M30.62%-6.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 20.79%-4.17M47.91%-12.33M73.03%-1.33M57.91%-1.56M38.11%-4.19M36.54%-5.26M36.66%-23.68M43.89%-4.91M45.06%-3.71M30.62%-6.77M
Basic earnings per share 35.29%-1.3268.39%-4.7773.44%-0.5167.21%-0.678.57%-1.6281.06%-2.0474.39%-15.0983.59%-1.9282.42%-1.8355.79%-7.56
Diluted earnings per share 35.29%-1.3268.39%-4.7773.44%-0.5167.21%-0.678.57%-1.6281.06%-2.0474.39%-15.0983.59%-1.9282.42%-1.8355.79%-7.56
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg